EAM Investors’s BioTelemetry, Inc. BEAT Stock Holding History

EAM Investors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-35,083	Closed	-$2.2M	–	344
2019 Q1	$2.2M	Sell	35,083 -22,279	-39%	-$1.53M	0.54%	52
2018 Q4	$3.43M	Sell	57,362 -39,576	-41%	-$2.38M	0.93%	5
2018 Q3	$6.25M	Sell	96,938 -5,075	-5%	-$283K	0.93%	1
2018 Q2	$4.59M	Buy	+102,013	New	+$4.07M	0.72%	10
2017 Q4	–	Sell	-67,816	Closed	-$2.24M	–	390
2017 Q3	$2.24M	Sell	67,816 -56,003	-45%	-$1.94M	0.3%	164
2017 Q2	$4.14M	Sell	123,819 -50,273	-29%	-$1.5M	0.68%	20
2017 Q1	$5.04M	Sell	174,092 -17,582	-9%	-$436K	0.79%	7
2016 Q4	$4.28M	Sell	191,674 -9,569	-5%	-$187K	0.57%	17
2016 Q3	$3.74M	Sell	201,243 -10,968	-5%	-$207K	0.5%	39
2016 Q2	$3.46M	Buy	+212,211	New	+$3.12M	0.52%	37
2016 Q1	–	Sell	-206,918	Closed	-$2.42M	–	401
2015 Q4	$2.42M	Sell	206,918 -43,314	-17%	-$548K	0.32%	152
2015 Q3	$3.06M	Buy	+250,232	New	+$3.19M	0.49%	56
2015 Q2	–	Sell	-165,667	Closed	-$1.47M	–	435
2015 Q1	$1.47M	Sell	165,667 -31,835	-16%	-$322K	0.17%	230
2014 Q4	$1.98M	Buy	+197,502	New	+$1.69M	0.28%	166
2013 Q4	–	Sell	-451,574	Closed	-$4.47M	–	424
2013 Q3	$4.47M	Buy	451,574 +225,657	+100%	+$1.78M	0.89%	3
2013 Q2	$1.33M	Buy	+225,917	New	+$760K	0.29%	122

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EAM Investors's BEAT Position: Q2 2019 in Review

EAM Investors sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 35,083 shares — an estimated $2.2M sold.

EAM Investors first reported a position in BEAT in Q2 2013 and held it in 16 quarters. The position peaked at $6.25M in Q3 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

EAM Investors reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
EAM Investors sold 35,083 BioTelemetry, Inc. shares in Q2 2019, an estimated $2.2M.
EAM Investors first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 16 quarters.
EAM Investors's BioTelemetry, Inc. position peaked at $6.25M in Q3 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on EAM Investors's 13F filing for Q2 2019, filed 14 Aug 2019.